434 results on '"Stratford M"'
Search Results
2. Nicotinamide as a Repair Inhibitor In Vivo: Studies Using Single and Fractionated X-Ray Doses in Mouse Skin and Kidneys
Catalog
Books, media, physical & digital resources
3. Rapid identification of the genus Dekkera/Brettanomyces, the Dekkera subgroup and all individual species
4. Acidulants and low pH
5. Organic acids and esters
6. Econometric Estimation of Spatial Patterns in Electricity Prices
7. A Switching Frontier Model for Imperfect Sample Separation Information: With an Application to Constrained Labor Supply
8. Collagen Metabolism in the Murine Colon Following X Irradiation
9. In vivo characterization of horseradish peroxidase with indole-3-acetic acid and 5-bromoindole-3-acetic acid for gene therapy of cancer
10. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: A retrospective cohort analysis
11. Yeast identification: reassessment of assimilation tests as sole universal identifiers
12. The preservative sorbic acid targets respiration, explaining the resistance of fermentative spoilage-yeast species
13. Biochemical studies on the toxic effects of chlorinated hydrocarbon insecticides during postnatal development
14. SOFT DRINKS | Microbiology
15. Activity of the plasma membrane H+ -ATPase and optimal glycolytic flux are required for rapid adaptation and growth of Saccharomyces cerevisiae in the presence of the weak-acid preservative sorbic acid
16. Mode of antimicrobial action of vanillin against Escherichia coli, Lactobacillus plantarum and Listeria innocua
17. PRESERVATIVES | Traditional Preservatives – Organic Acids
18. Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity
19. Zygosaccharomyces lentus: a significant new osmophilic, preservative-resistant spoilage yeast, capable of growth at low temperature
20. AROMATIC OXIME DERIVATIVES ARE SUBSTRATES FOR TUMOUR-ASSOCIATED CYTOCHROME P450s AND PRODRUGS FOR NITRIC OXIDE
21. A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer
22. Weak-acid preservatives: modelling microbial inhibition and response
23. Evidence that sorbic acid does not inhibit yeast as a classic 'weak acid preservative'
24. Characterization of the diffusion properties of different gadolinium-based MRI contrast agents after ultrasound induced blood–brain barrier permeabilization
25. Pharmacokinetic Studies on Some Novel (2-Nitro-1-Imidazolyl) Propanolamine Radiosensitizers
26. Systemic inflammation alters central 5-HT function as determined by pharmacological MRI (vol 75, pg 177, 2013)
27. Increasing radiosensitivity by alleviating tumour hypoxia: a drug screen reveals atovaquone as a clinical candidate
28. Sample Selection in Appalachian Research
29. PHARMACOKINETIC ANALYSIS AND CLINICAL RESULTS OF THE PHASE 1 DOSE ESCALATION AND EXPANSION CXD101 TRIAL IN RELAPSED, REFRACTORY LYMPHOMA
30. The effect of depression on health care utilization and costs in patients with type 2 diabetes
31. A novel biosensor for quantitative monitoring of on-target activity of paclitaxel
32. Development of an enzymatic pretargeting strategy for dual-modality imaging
33. Cofactor Strap regulates oxidative phosphorylation and mitochondrial p53 activity through ATP synthase
34. Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo
35. The antifungal action of 1,10-o-phenanthroline and EDTA is mediated through zinc chelation and involves cell wall construction
36. The importance of Zn2+ ions for fungal growth
37. OC-12: Permeabilisation of the Blood-Brain Barrier at Sites of Metastasis Enables Targeted Therapy Delivery
38. Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
39. The weak acid preservative sorbic acid inhibits conidial germination and mycelial growth of Aspergillus niger through intracellular acidification
40. A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB)
41. ChemInform Abstract: Prodrugs for Targeting Hypoxic Tissues: Regiospecific Elimination of Aspirin from Reduced Indolequinones.
42. Phase I pharmacokinetic and pharmacodynamic evaluation of the vascular disrupting agent OXi4503 in patients with advanced solid tumors.
43. A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer
44. A PET imaging study of the vascular disruptive agent OXi4503 to confirm in vivo mechanism of action in a phase I trial
45. A phase I/II trial of radioimmunotherapy with 131Iodine labelled A5B7 anti-CEA antibody (131I-A5B7) in combination with Combretastatin-A4-Phosphate (CA4P) in advanced gastrointestinal carcinomas
46. Phase I evaluation of vascular disrupting agent OXi4503
47. Phase I evaluation of OXi4503, a vascular disrupting agent, in patients with advanced solid tumours
48. Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents
49. Molecular evidence for the existence of natural hybrids in the genus
50. Is sensitization with nicotinamide and carbogen dependent on nicotinamide concentration at the time of irradiation?
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.